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NOTABLENOTES
Mór Cohen, Better Known asMoriz Kaposi
Filippo Pesapane, MD; Gianluca Nazzaro, MD; Antonella Coggi, MD; Raffaele Gianotti, MD
Today, Moriz Kaposi is remembered for the first description, in 1872, of
the entity that bears his name,1 but he was also one of the founders of
the Viennese School of Dermatology.
Kaposiwasborn in 1837 inapoorJewish family.Thestoryofhisname
is curious: his first name is written “Moritz” in the records of the Jewish




after his conversion to theCatholic faith, he changed it in 1871 toKaposi,
in reference tohisbirth townKaposvár, in theAustro-HungarianEmpire.
It is still debatedwhyhechangedhis surname; it is unlikely tohavebeen
due to thepressuresof anti-SemitismbecauseKaposiwasnot anoppor-
tunist, and at that time hewaswell established in his career. According
tohisownwords,MórCohenchangedhissurnametoavoidconfusionwith
5 other physicians named similarly in the Vienna School ofMedicine.2
In 1886 Kaposi marriedMartha Hebra, daughter of Ferdinand Ritter
vonHebrawhowashismentorandwithwhomheauthoredthebookText-
book of SkinDiseases in 1878. Kaposi’smainwork, however,wasPathol-
ogy and Therapy of the Skin Diseases in Lectures for Practical Physicians
andStudents,whichbecameoneof themost significantbooks in thehis-
tory of dermatology and was translated into many languages. Kaposi’s
remarkable skill with languages stood him in good stead; he was fluent
inHungarian, German, and French. In addition, hewas versed in English
and of course Latin, the official language of the Empire.3
WhileHebra isconsideredthe“fatherofdermatology,”Kaposiwasone
of the first to establish dermatology on its anatomical pathology scien-
tific basis. In his field, Kaposi concerned himself chiefly with syphilis, its
clinicalpresentation, itsetiology,andtreatment.HewrotewithHebrasome
oftheearlydescriptionsofcutaneous lupuserythematosusandnotedthe
systemic involvement in 1872, and in 1875 he described the rash as “but-
terfly.”Kaposi usedhis skills of observationanddescription to first report
anddelineatemanyotherentities, suchasxerodermapigmentosum,dia-
betic and leukemic skin changes, syringoma, gangrenous zoster or ec-
zema herpeticum, and pustulosis varioliformis acuta, which later be-
came known as Kaposi varicelliform eruption or eczema herpeticatum.
Kaposi died peacefully in his sleep in Vienna at only 65 years of age.
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